1 |
Wiseman, H. and Halliwell, B. (1996). Damage to DNA by reactive
oxygen and nitrogen species: role in inflammatory disease
and progression to cancer. J. Biol. Chem. 313, 17-29.
|
2 |
Wolter, F., Akoglu, B., Clausnitzer, A. and Stein, J. (2001).
Down-regulation of the cyclin D1/cdk4 complex occurs during
resveratrol-induced cell cycle arrest in colon cancer cell
lines. J. Nutr. 131, 2197-2203.
DOI
|
3 |
Pugh, S. and Thomas, G. A. (1994). Patients with adenomatous
polyps and carcinomas have increased colonic mucosal
prostaglandin . Gut 35, 675-678.
DOI
|
4 |
Rigas, B., Goldman, I. S. and Levine, L. (1993). Altered eicosanoid
levels in human colon cancer. J. Lab. Clin. Med. 122, 518-523.
|
5 |
Sexton, E., van Themsche, C., Leblanc, K., Parent, S., Lemoine,
P. and Asselin, E. (2006). Resveratrol interferes with AKT
activity and triggers apoptosis in human uterine cancer cells.
Mol. Cancer 5, 45.
DOI
ScienceOn
|
6 |
Shao, J., Jung, C., Liu, C. and Sheng, H. (2005). Prostaglandin
stimulates the -catenin/T cell factor-dependent transcription
in colon cancer. J. Biol. Chem. 280, 26565-26572.
DOI
|
7 |
Shao, J., Lee, S. B., Guo, H., Evers, B. M. and Sheng, H.
(2003). Prostaglandin stimulates the growth of colon cancer
cells via induction of amphiregulin. Cancer Res. 63,
5218-5223.
|
8 |
Sheng, H., Shao, J., Washington, M. K. and DuBois, R. N.
(2001). Prostaglandin increases growth and motility of colorectal
carcinoma cells. J. Biol. Chem. 276, 18075-18081.
DOI
|
9 |
Sugimoto, Y. and Narumiya, S. (2007). Prostaglandin E receptors.
J. Biol. Chem. 282, 11613-11617.
DOI
|
10 |
Torok, N. J., Higuchi, H., Bronk, S. and Gores, G. J. (2002).
Nitric oxide inhibits apoptosis downstream of cytochrome C
release by nitosylating caspase-9. Cancer Res. 62, 1648-
1653.
|
11 |
Ulrich, C. M., Bigler, J. and Potter, J. D. (2006). Non-steroidal
anti-inflammatory drugs for cancer prevention: promise, perils,
and pharmacogenetics. Nat. Rev. Cancer 6, 130-140.
DOI
|
12 |
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K. and DuBois,
R. N. (2005). Prostaglandin enhances intestinal adenoma
growth via activation of the Ras-mitogen-activated protein
kinase cascade. Cancer Res. 65, 1822-1829.
DOI
|
13 |
Hull, M. A., Ko, S. C. W. and Hawcroft, G. (2004). Prostaglandin
EP receptors: targets for treatment and prevention of colorectal
cancer? Mol. Cancer Ther. 3, 1031-1039.
DOI
|
14 |
Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D. and
Weinstein, I. B. (2002). Resveratrol induces growth inhibition,
S-phase arrest, apoptosis, and changes in biomarker
expression in several human cancer cell lines. Clin. Cancer
Res. 8, 893-903.
|
15 |
Kawamori, T., Uchiya, N., Sugimura, T. and Wakabayashi, K.
(2003). Enhancement of colon carcinogenesis by prostaglandin
administration. Carcinogenesis 24, 985-990.
DOI
|
16 |
Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y. and Lin, J. K.
(2003). Resveratrol-induced G2 arrest through the inhibition
of CDK7 and kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65, 1053-1060.
DOI
ScienceOn
|
17 |
Mutoh, M., Takahashi, M., Fukuda, K., Matsushima-Hibiya, Y.,
Mutoh, H., Sugimura, T. and Wakabayashi, K. (2000). Suppression
of cyclooxygenase-2 promoter-dependent transcriptional
activity in colon cancer cells by chemopreventive
agents with a resorcin-type structure. Carcinogenesis 21,
959-963.
DOI
|
18 |
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D. and
Tarnawski, A. S. (2002). Prostaglandin transactivates EGF
receptor: a novel mechanism for promoting colon cancer
growth and gastrointestinal hypertrophy. Nat. Med. 8, 289-
293.
DOI
|
19 |
Nam, K. A., Heo, Y. H. and Lee, S. K. (2003). Cytotoxic activity
and G2/M cell cycle arrest mediated by antofine, a
phenanthroindolizidine alkaloid isolated from Cynanchum
paniculatum. Planta Med. 69, 21-25.
DOI
|
20 |
Pai, R., Nakamura, T., Moon, W. S. and Tarnawski, A. S.
(2003). Prostaglandins promote colon cancer cell invasion:
signaling by cross-talk between two distinct growth factor
receptors. FASEB J. 17, 1640-1647.
DOI
|
21 |
Buchanan, F. G., Wang, D., Bargiacchi, F. and DuBois, R. N.
(2003). Prostaglandin regulates cell migration via the
intracellular activation of the epidermal growth factor
receptor. J. Biol. Chem. 278, 35451-35457.
DOI
|
22 |
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M.
and Gutkind, J. S. (2005). Prostaglandin promotes colon
cancer cell growth through a Gs-axin--catenin signaling
axis. Science 310, 1504-1510.
DOI
ScienceOn
|
23 |
DuBois, R. N., Radhika, A., Reddy, B. S. and Entingh, A. J.
(1996). Increased cyclooxygenase-2 levels in carcinogeninduced
rat colonic tumors. Gastroenterology 110, 1259-
1262.
DOI
|
24 |
Eberhart, G. E., Coffey, R. J., Radhika, A., Giardiello, F. M.,
Ferrenbach, S. and DuBois, R. N. (1994). Up-regulation of
cyclooxygenase-2 gene expression in human colorectal
adenoma and adnocarcinomas. Gastroenterology 107,
1183-1188.
DOI
|
25 |
Fujino, H., West, K. A. and Regan, J. W. (2002). Phosphorylation
of glycogen synthase-3 and stimulation of T-cell factor
signaling following activation of EP2 and EP4 prostanoid
receptors by prostaglandin E2. J. Biol. Chem. 277, 2614-
2619.
DOI
|
26 |
Bhat, K. P. L. and Pezzuto, J. M. (2002). Cancer chemopreventive
activity of resveratrol. Ann. N.Y. Acad. Sci. 957,
210-229.
DOI
|
27 |
Giardiello, F. M., Yang, V. W., Hylind, L. M., Krush, A. J.,
Petersen, G. M., Trimbath, J. D., Piantadosi, S., Garrett, E.,
Geiman, D. E., Hubbard, W., Offerhaus, G. J. and Hamilton,
S. R. (2002). Primary chemoprevention of familial
adenomatous polyposis with sulindac. New Engl. J. Med.
346, 1054-1059.
DOI
|
28 |
Hansen-Petrik, M. B., McEntee, M. F., Jull, B., Shi, H., Zemel,
M. B. and Whelan J. (2002). Prostaglandin protects
intestinal tumors from nonsteroidal anti-inflammatory druginduced
regression in Apc(Min/+) mice. Cancer Res. 62,
403-408.
|
29 |
Hsieh, T. C. and Wu, J. M. (1999). Differential effects on growth,
cell cycle arrest, and induction of apoptosis by resveratrol in
human prostate cancer cell lines. Exp. Cell Res. 249,
109-115.
DOI
|